The appearance is white powder, CAS number is 79350-37-1, and the molecular formula is C16H15N5O7S2. Antibacterial activity was demonstrated by inhibiting the synthesis of bacterial cell walls.

Market Analysis and Insights: Global Cefixime Market
The global Cefixime market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Cefixime Scope and Market Size
The global Cefixime market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cefixime market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %

Segment by Application
Cefixime Tablets
Cefixime Capsule

The Cefixime market is analysed and market size information is provided by regions (countries). Segment by Application, the Cefixime market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
ACS Dobfar
Covalent Laboratories
Luoxin Pharmaceutical
Nishchem International
Dhanuka Laboratories
Reva Pharma
Orchid Pharma
Virchow Healthcare
Qilu Pharmaceutial
Guangzhou Pi & Pi Biotech
Athos Chemicals
Chegndu Brilliant Pharmaceutical